Clinical Application of New Advances in the Treatment of Head and Neck Cancer

Review the latest data and expert guidance on managing patients with head and neck cancer. This comprehensive program features clinical commentaries short-form video learning episodes updates to the online Interactive Decision Support Tool and downloadable slides.

Share

Program Content

Activities

HNSCC and COVID-19
How We Are Managing Outpatient Head and Neck Cancer Care During the COVID-19 Pandemic
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2020

Expires: July 14, 2021

Immunotherapy in HNSCC
The Evolution of Immunotherapy in Head and Neck Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 08, 2020

Expires: October 07, 2021

H&N Cancer: <i>NTRK</i> Fusions
How I Manage Patients With NTRK Fusion–Positive Head and Neck Cancer
Case Challenge
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

Immunotherapy AEs in HNSCC
Managing Immune-Related Adverse Events in Head and Neck Cancer
Case Challenge
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: February 12, 2021

Expires: February 11, 2022

Activities

Frontline HNSCC Immunotherapy
Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2020

Expires: November 09, 2021

HNSCC Tx Slides
The Current Treatment Landscape in Head and Neck Cancer: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

NTRK Fusions in H&N Slides
Rationale for Targeting NTRK Fusions in Head and Neck Cancers: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 21, 2020

Expires: December 20, 2021

NTRK Inhibitors in H&N Slides
Management Options for NTRK Fusion–Positive Patients With Head and Neck Cancer: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2020

Expires: December 21, 2021

Future HNSCC Immunotherapy
Exploring Future Roles for Immune-Oncology in Head and Neck Cancer: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 05, 2021

Expires: January 04, 2022

NTRK Fusion Testing: Slides
NTRK Fusions: Whom to Test? When to Test?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 05, 2021

Expires: January 04, 2022

irAEs in Head and Neck Cancer
Strategies for Managing Immune-Related Adverse Events in Patients With Head and Neck Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 09, 2021

Expires: March 08, 2022

Head, Neck Cancer Testing Slides
The Importance of Molecular Testing in Head and Neck Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2021

Expires: March 17, 2022

Immune Escape in HNSCC
The Role of the Immune System and Immune Escape in Head and Neck Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2021

Expires: March 21, 2022

IO Biomarkers in HNSCC
Predictive Biomarkers for Immunotherapy in HNSCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2021

Expires: March 21, 2022

Head & Neck Cancer Tx
ExpressPoints: Clinical Application of New Advances in the Treatment of Head and Neck Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 09, 2021

Expires: April 08, 2022

Activities

Head and Neck Cancer Tool
Expert Therapy Recommendations for Recurrent Locoregionally Advanced and Metastatic Head and Neck Cancer
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: April 06, 2021

Expires: April 05, 2022

Activities

Frontline HNSCC Immunotherapy
Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2020

Expires: November 09, 2021

Treating Head and Neck Cancer
The Current Treatment Landscape in Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

Future HNSCC Immunotherapy
Exploring Future Roles for Immune-Oncology in Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2020

Expires: December 17, 2021

NTRK Fusions in H&N
Rationale for Targeting NTRK Fusions in Head and Neck Cancers
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 21, 2020

Expires: December 20, 2021

Testing for <em>NTRK</em> Fusions
NTRK Fusions: Who To Test? When To Test?
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 21, 2020

Expires: December 20, 2021

NTRK Inhibitor Management
Management Options for NTRK Fusion-positive Patients With Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2020

Expires: December 21, 2021

irAEs in Head and Neck Cancer
Strategies for Managing Immune-Related Adverse Events in Patients With Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2021

Expires: March 07, 2022

Head, Neck Cancer Testing
The Importance of Molecular Testing in Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2021

Expires: March 17, 2022

Immune Escape in HNSCC
The Role of the Immune System and Immune Escape in Head and Neck Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2021

Expires: March 21, 2022

IO Biomarkers in HNSCC
Predictive Biomarkers for Immunotherapy in HNSCC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2021

Expires: March 21, 2022

Faculty

cover img faculity

Barbara Burtness, MD

Anthony N. Brady Professor of Medicine
Yale School of Medicine
Chief Translational Research Officer
Division Chief
Head and Neck/Sarcoma Oncology
Co-leader
Developmental Therapeutics Program
Director
Yale Head and Neck SPORE
Yale Cancer Center
Chair
ECOG-ACRIN Cancer Research Group
New Haven, Connecticut

cover img faculity

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut

cover img faculity

Elisabeth King, RN, FNP, AGN, AOCNP

Executive Director of Genomics and Precision Medicine
City of Hope
Duarte, California

cover img faculity

Cristina P. Rodriguez, MD

Associate Professor
Department of Medicine
University of Washington
Seattle, Washington

cover img faculity

Daniel Zalinov, PA-C

Internal Medicine
Atrium Health
Charlotte, North Carolina

cover img faculity

Dan P. Zandberg, MD

Associate Professor of Medicine and Otolaryngology
Director
, Head and Neck and Thyroid Cancer Disease Sections
Division of Hematology/Oncology
Medical Oncology Co-Leader, Head and Neck Program
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

cover img faculity

Robert L. Ferris, MD, PhD

Director
UPMC Hillman Cancer Center
Hillman Professor of Oncology
Associate Vice Chancellor for Cancer Research
Co-Director, 
Tumor Microenvironment Center
Profressor of Otolaryngology, of Immunology, and of Radiation Oncology
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

cover img faculity

Ranee Mehra, MD

Professor of Medicine
Department of Hematology/Oncology
University of Maryland, Baltimore
Director
Head and Neck Medical Oncology
Marlene and Stewart Greenebaum Comprehensive Cancer Center
University of Maryland Medical Center
Baltimore, Maryland

cover img faculity

Jared Weiss, MD

Assistant Professor of Medicine
Attending Physician

Department of Hematology and Oncology
University of North Carolina
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.